Skip to content
Markets News
Stocks1 min read

Teleflex Vascular Growth Faces Pressure From Higher Costs

Makkler Newsroom
October 6, 2026

Second-quarter Vascular revenue rose, but tariffs and acquisition-related costs weighed on Teleflex’s adjusted margins.

Key takeaways

  • Vascular revenue rose 9% on a reported basis in the second quarter.
  • Asia net revenue increased 59.5% to $76 million.
  • Adjusted operating margin fell 520 basis points to 19.6%.

Teleflex’s Vascular business grew in the second quarter of 2026, while tariffs and acquisition-related costs weighed on margins. As of 3:51 p.m. UTC Tuesday, shares traded at $125.99, up 0.6% from the previous close.

Vascular revenue rose 9% on a reported basis and 8% on a pro forma adjusted constant-currency basis. In late July, the FDA approved EZPLAZ Freeze Dried Plasma, which the company said was the first freeze-dried plasma licensed by the agency. Management described the underlying Vascular market as a mid-single-digit growth market.

Asia net revenue increased 59.5% to $76 million, mainly reflecting $27.7 million in acquired revenue. Operating profit in the region rose 235.3% to $15 million, despite higher operating and amortization expenses tied to the acquisition.

Margins declined: adjusted gross margin fell 280 basis points year over year, while adjusted operating margin dropped 520 basis points to 19.6%. Teleflex cited tariffs, the acquired business’s lower gross margin profile, higher operating expenses and increased research and development investment.

The company ended the quarter with $300.2 million in cash and cash equivalents. After its OEM divestiture, pro forma net leverage fell to about 1.9 times from 2.8 times at quarter-end. Teleflex continues to target about $800 million in debt reduction from strategic divestiture proceeds.

Zacks Consensus Estimates for 2026 earnings per share rose 1.8% in the past 30 days to $7.22. Its revenue estimate is $2.28 billion, which implies a 23.1% decline from the prior year’s reported figure.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.